Wedbush Starts Fusion Pharmaceuticals (FUSN) at Outperform

July 21, 2020 6:32 AM EDT
Get Alerts FUSN Hot Sheet
Price: $8.25 +3.00%

Rating Summary:
    3 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 22 | Down: 26 | New: 45
Trade Now! 
Join SI Premium – FREE

Wedbush analyst David Nierengarten initiates coverage on Fusion Pharmaceuticals (NASDAQ: FUSN) with a Outperform rating and a price target of $25.00.


For an analyst ratings summary and ratings history on Fusion Pharmaceuticals click here. For more ratings news on Fusion Pharmaceuticals click here.


Shares of Fusion Pharmaceuticals closed at $15.28 yesterday.


You May Also Be Interested In





Related Categories

New Coverage